In honor of Crohn’s and Colitis Awareness Week, Nov. 30 – Dec. 7, review AGA education programs and resources to help you and your patients with IBD better understand and manage the condition.
IBD Parenthood Project
The AGA IBD Parenthood Project aims to address misperceptions and fears women with IBD and their health care providers experience throughout all phases of family planning. Visit www.IBDParenthoodProject.org for resources to share with your patients, including a downloadable toolkit with visual and patient-friendly education.
The education for health care providers section has free learning activities and videos designed to support you in all aspects of providing care before, during and after pregnancy.
What patients need to know about living with IBD
The content in this series will help your patients understand IBD, the difference between ulcerative colitis and Crohn’s disease, disease management, and surgical, medical and lifestyle treatment options. Available online and in the AGA Patient Education section of Clinical Gastroenterology and Hepatology. AGA videos are available in English and Spanish.
Understanding biologics and biosimilars
Help your patients better understand their treatment options by sharing AGA’s patient education on biologics and biosimilars:
- Available in English and Spanish.
- AGA videos in English and Spanish.
- What are biologics and biosimilar drugs? Order copies for your office at www.agaresources.com/order_biosimilars.php.
#ColitisConversations Facebook Live
Co-sponsored by AGA and The Mighty, the #ColitisConverations Facebook Live program featured a transparent conversation between patients and experts about treatment goals and useful GI conversations.
Share these patient education resources on your practice website or social media channels and tag @AmerGastroAssn.
Health care provider resources
Connecting Virtually | Jan. 21-24, 2021
Join professionals, across all disciplines, in a collaborative, patient-centered, virtual learning experience.
Address common misperceptions about risks associated with IBD and its treatment during pregnancy.
Navigate the clinical implications for the use of biosimilars for IBD at different points of care, including beginning treatment, a potential, payor-necessitated switch to biosimilars and general questions about switching.
Learn how to individualize treatment for patients with moderate to severe ulcerative colitis. Enter the details of your patient case using dropdown menus and then receive a case-specific treatment recommendation from five experts.